Sidenafil dimer impurity is a dimeric derivative formed via coupling of two Sidenafil moieties through a sulfonamide bridge, resulting in a symmetrical bis-piperazinylpyrazinyl core. The structure retains key pharmacophoric elements of the parent compound, including pyrazinyl, piperazine, and sulfonamide functionalities, while introducing intermolecular ester linkages. This impurity arises during synthetic processes due to dimerization under coupling conditions. It serves as a critical HPLC reference standard for quantifying dimeric byproducts in Sidenafil active pharmaceutical ingredient (API) batches.
 Isomer.png)
